>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
miR-155通过调控Th9细胞分化及相关因子表达参与脑梗死免疫发病机制的研究
作者:贺丹  徐峻峰 
单位:鄂州市中心医院 神经内科, 湖北 鄂州 436000
关键词:脑梗死 微小RNA-155 Th9细胞 免疫 大鼠 
分类号:R743.33
出版年·卷·期(页码):2022·41·第三期(408-414)
摘要:

目的:探究微小RNA(microRNA,miR)-155参与脑梗死的免疫发病机制。方法:通过栓线法构建脑梗死大鼠模型。将30只脑梗死大鼠随机均分为脑梗死组和脑梗死+miR-155抑制剂组。另取15只假手术大鼠作为对照组。检测各组神经功能(mNSS评分)、梗死体积、神经元凋亡、炎症细胞因子水平,分析脑组织血液中Th9细胞比例和白细胞介素(IL)-9的水平,以及T淋巴细胞中miR-155、转录因子PU.1和IRF4蛋白的表达水平。结果:脑梗死组mNSS评分、梗死体积、凋亡指数、IL-1β水平、IL-6水平、Th9细胞比例、IL-9水平、miR-155以及PU.1、IRF4蛋白的表达水平均显著高于对照组(均P<0.05)。脑梗死+miR-155抑制剂组mNSS评分、梗死体积、凋亡指数、IL-1β水平、IL-6水平、Th9细胞比例、IL-9水平、miR-155以及PU.1、IRF4蛋白的表达水平均显著低于脑梗死组(均P<0.05),但均显著高于对照组(均P<0.05)。结论:miR-155可能通过提高Th9细胞比例和IL-9的表达促进免疫炎症反应,从而导致神经元损伤参与脑梗死进展。

Objective: To explore the effects of microRNA(miR)-155 in the immune pathogenesis of cerebral infarction animal models. Methods: The rat model of cerebral infarction was constructed by the thread embolism method. Thirty rats with cerebral infarction were randomly divided into cerebral infarction group(n=15) and cerebral infarction+miR-155 inhibitor group(n=15). Fifteen sham-operated rats served as the control group. Nerve function, infarct volume, neuronal apoptosis, inflammatory cytokine levels in each group were detected, so were the proportion of Th9 cells and IL-19 levels in brain tissue, miR-155, protein expressions of PU.1 and IRF4 in T lymphocytes. Results: The mNSS score, infarct volume, apoptosis index, IL-1β, IL-6, Th9 cell ratio, IL-9 level, miR-155 and PU.1 and IRF4 protein expression levels in the cerebral infarction group were significantly higher than those in the control group(P<0.05). The mNSS score, infarct volume, apoptosis index, IL-1β, IL-6, Th9 cell ratio, IL-9 level, miR-155 and PU.1 and IRF4 protein expression levels in the cerebral infarction+miR-155 inhibitor group were significantly lower than those in the cerebral infarction group(P<0.05), and were significantly higher than those in control group(P<0.05). Conclusion: miR-155 may promote immune inflammatory response by increasing the proportion of Th9 and the expression of IL-9, leading to neuronal damage and participating in the progression of cerebral infarction.

参考文献:

[1] UMEMURA T,HACHISUKA K,MIYACHI H,et al.Clinical outcomes of cerebral infarction in nonagenarians compared among four age groups[J].Neurol Sci,2020,41(9):2471-2476.
[2] TAKEDA H,YAMAGUCHI T,YANO H,et al.Microglial metabolic disturbances and neuroinflammation in cerebral infarction[J].J Pharmacol Sci,2021,145(1):130-139.
[3] WEITBRECHT L,BERCHTOLD D,ZHANG T,et al.CD4+ T cells promote delayed B cell responses in the ischemic brain after experimental stroke[J].Brain Behav Immun,2021,91(1):601-614.
[4] HU X,FENG J,DENG S,et al.Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy[J].J Nephrol,2020,33(5):1027-1036.
[5] KODAMA H,TAKAHASHI S,OKAZAKI T,et al.Association between false lumen segmental arteries and spinal cord ischemia in type A acute aortic dissection[J].J Cardiovasc Surg,2020,61(2):226-233.
[6] CORREIA de SOUSA M,GJORGJIEVA M,DOLICKA D,et al.Deciphering miRNAs' action through miRNA editing[J].Int J Mol Sci,2019,20(24):6249-6251.
[7] WANG D,WANG L,BAI L,et al.Effects of inhibition of miR-155-5p in neural stem cell subarachnoid transplant on rats with cerebral infarction[J].Hum Gene Ther Methods,2019,30(5):184-193.
[8] CHEN N,FENG L,QU H,et al.Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia[J].Oncol Rep,2018,39(6):3064-3072.
[9] 王梓,邢宏义,范宇葱,等.缺血预处理通过抑制精氨酰-tRNA合成酶和Caspase-3表达减少脑梗死大鼠脑细胞的凋亡[J].中华神经医学杂志,2020,19(12):1214-1221.
[10] CHAI Z,GONG J,ZHENG P,et al.Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro[J].Biol Res,2020,53(1):17-22.
[11] YANG J,YAN H,LI S,et al.Berberine ameliorates MCAO induced cerebral ischemia/reperfusion injury via activation of the BDNF-TrkB-PI3K/Akt signaling pathway[J].Neurochem Res,2018,43(3):702-710.
[12] FELLING R J,RAFAY M F,BERNARD T J,et al.Predicting recovery and outcome after pediatric stroke:results from the international pediatric stroke study[J].Ann Neurol,2020,87(6):840-852.
[13] ZHANG M,LU H,XIE X,et al.TMEM175 mediates lysosomal function and participates in neuronal injury induced by cerebral ischemia-reperfusion[J].Mol Brain,2020,13(1):113-118.
[14] MA F,SUN P,ZHANG X,et al.Endothelium-targeted deletion of the miR-15a/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke[J].Sci Signal,2020,13(626):5686-5689.
[15] HENRY R J,DORAN S J,BARRETT J P,et al.Inhibition of miR-155 limits neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice[J].Neurotherapeutics,2019,16(1):216-230.
[16] SHI Y,LI K,XU K,et al.MiR-155-5p accelerates cerebral ischemia-reperfusion injury via targeting DUSP14 by regulating NF-κB and MAPKs signaling pathways[J].Eur Rev Med Pharmacol Sci,2020,24(3):1408-1419.
[17] MALONE K,AMU S,MOORE A C,et al.The immune system and stroke:from current targets to future therapy[J].Immunol Cell Biol,2019,97(1):5-16.
[18] VYAS S P,HANSDA A K,KAPLAN M H,et al.Calcitriol regulates the differentiation of IL-9-secreting Th9 cells by modulating the transcription factor PU.1[J].J Immunol,2020,204(5):1201-1213.
[19] TAN S,SHAN Y,WANG Y,et al.Exacerbation of oxygen-glucose deprivation-induced blood-brain barrier disruption:potential pathogenic role of interleukin-9 in ischemic stroke[J].Clin Sci,2017,131(13):1499-1513.
[20] TAN S,SHAN Y,LIN Y,et al.Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A[J].FASEB J,2019,33(3):4376-4387.
[21] TIAN K,XU W.MiR-155 regulates Th9 differentiation in children with methicillin-resistant Staphylococcus aureus pneumonia by targeting SIRT1[J].Hum Immunol,2021,82(10):775-781.
[22] WANG C R,ZHU H F,ZHU Y.Knockout of microRNA-155 ameliorates the Th17/Th9 immune response and promotes wound healing[J].Curr Med Sci,2019,39(6):954-964.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412825 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364